Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Ketogenic diet attenuates hepatopathy in mouse model of respiratory chain complex III deficiency caused by a Bcs1l mutation.

Purhonen J, Rajendran J, Mörgelin M, Uusi-Rauva K, Katayama S, Krjutskov K, Einarsdottir E, Velagapudi V, Kere J, Jauhiainen M, Fellman V, Kallijärvi J.

Sci Rep. 2017 Apr 19;7(1):957. doi: 10.1038/s41598-017-01109-4.

2.

Distinct membrane properties are differentially influenced by cardiolipin content and acyl chain composition in biomimetic membranes.

Pennington ER, Fix A, Sullivan EM, Brown DA, Kennedy A, Shaikh SR.

Biochim Biophys Acta. 2017 Feb;1859(2):257-267. doi: 10.1016/j.bbamem.2016.11.012. Epub 2016 Nov 24.

PMID:
27889304
3.

DHA but Not EPA Emulsions Preserve Neurological and Mitochondrial Function after Brain Hypoxia-Ischemia in Neonatal Mice.

Mayurasakorn K, Niatsetskaya ZV, Sosunov SA, Williams JJ, Zirpoli H, Vlasakov I, Deckelbaum RJ, Ten VS.

PLoS One. 2016 Aug 11;11(8):e0160870. doi: 10.1371/journal.pone.0160870. eCollection 2016.

4.

Effect of omega-3 fatty acid oxidation products on the cellular and mitochondrial toxicity of BDE 47.

Yeh A, Kruse SE, Marcinek DJ, Gallagher EP.

Toxicol In Vitro. 2015 Jun;29(4):672-80. doi: 10.1016/j.tiv.2015.01.015. Epub 2015 Feb 7.

5.

Effect of a high-protein diet on development of heart failure in response to pressure overload.

Ribeiro RF Jr, Dabkowski ER, O'Connell KA, Xu W, Galvao Tde F, Hecker PA, Shekar KC, Stefanon I, Stanley WC.

Appl Physiol Nutr Metab. 2014 Feb;39(2):238-47. doi: 10.1139/apnm-2013-0274. Epub 2013 Sep 11.

6.

Dietary saturated fat and docosahexaenoic acid differentially effect cardiac mitochondrial phospholipid fatty acyl composition and Ca(2+) uptake, without altering permeability transition or left ventricular function.

O'Connell KA, Dabkowski ER, de Fatima Galvao T, Xu W, Daneault C, de Rosiers C, Stanley WC.

Physiol Rep. 2013 Jun;1(1):e00009. doi: 10.1002/phy2.9. Epub 2013 Jun 12.

7.
8.

Evaluation of docosahexaenoic acid in a dog model of hypertension induced left ventricular hypertrophy.

Stanley WC, Cox JW, Asemu G, O'Connell KA, Dabkowski ER, Xu W, Ribeiro RF Jr, Shekar KC, Hoag SW, Rastogi S, Sabbah HN, Daneault C, des Rosiers C.

J Cardiovasc Transl Res. 2013 Dec;6(6):1000-10. doi: 10.1007/s12265-013-9511-y. Epub 2013 Sep 25.

9.

Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failure.

Dabkowski ER, O'Connell KA, Xu W, Ribeiro RF Jr, Hecker PA, Shekar KC, Daneault C, Des Rosiers C, Stanley WC.

Cardiovasc Drugs Ther. 2013 Dec;27(6):499-510. doi: 10.1007/s10557-013-6487-4.

10.

N-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice.

Williams JJ, Mayurasakorn K, Vannucci SJ, Mastropietro C, Bazan NG, Ten VS, Deckelbaum RJ.

PLoS One. 2013;8(2):e56233. doi: 10.1371/journal.pone.0056233. Epub 2013 Feb 20.

11.

Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long-term aldosterone infusion.

Asemu G, O'Connell KA, Cox JW, Dabkowski ER, Xu W, Ribeiro RF Jr, Shekar KC, Hecker PA, Rastogi S, Sabbah HN, Hoppel CL, Stanley WC.

Am J Physiol Heart Circ Physiol. 2013 Feb 15;304(4):H514-28. doi: 10.1152/ajpheart.00674.2012. Epub 2012 Dec 15.

12.

Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids.

Russell FD, Bürgin-Maunder CS.

Mar Drugs. 2012 Nov 13;10(11):2535-59. doi: 10.3390/md10112535. Review.

13.

Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.

Galvao TF, Khairallah RJ, Dabkowski ER, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, Sabbah HN, Rastogi S, Daneault C, Des Rosiers C, Stanley WC.

Am J Physiol Heart Circ Physiol. 2013 Jan 1;304(1):H12-21. doi: 10.1152/ajpheart.00657.2012. Epub 2012 Oct 26.

14.

Dietary Omega-3 Fatty Acids Do Not Change Resistance of Rat Brain or Liver Mitochondria to Ca(2+) and/or Prooxidants.

Stavrovskaya IG, Bird SS, Marur VR, Baranov SV, Greenberg HK, Porter CL, Kristal BS.

J Lipids. 2012;2012:797105. doi: 10.1155/2012/797105. Epub 2012 Aug 27.

15.

CardioNet: a human metabolic network suited for the study of cardiomyocyte metabolism.

Karlstädt A, Fliegner D, Kararigas G, Ruderisch HS, Regitz-Zagrosek V, Holzhütter HG.

BMC Syst Biol. 2012 Aug 29;6:114. doi: 10.1186/1752-0509-6-114.

16.

Omega-3 fatty acid supplementation and cardiovascular disease.

Jump DB, Depner CM, Tripathy S.

J Lipid Res. 2012 Dec;53(12):2525-45. doi: 10.1194/jlr.R027904. Epub 2012 Aug 17. Review.

17.
18.

Improved mitochondrial function with diet-induced increase in either docosahexaenoic acid or arachidonic acid in membrane phospholipids.

Khairallah RJ, Kim J, O'Shea KM, O'Connell KA, Brown BH, Galvao T, Daneault C, Des Rosiers C, Polster BM, Hoppel CL, Stanley WC.

PLoS One. 2012;7(3):e34402. doi: 10.1371/journal.pone.0034402. Epub 2012 Mar 30.

19.

Models of plasma membrane organization can be applied to mitochondrial membranes to target human health and disease with polyunsaturated fatty acids.

Raza Shaikh S, Brown DA.

Prostaglandins Leukot Essent Fatty Acids. 2013 Jan;88(1):21-5. doi: 10.1016/j.plefa.2012.03.004. Epub 2012 Mar 29. Review.

20.

Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.

Stanley WC, Dabkowski ER, Ribeiro RF Jr, O'Connell KA.

Circ Res. 2012 Mar 2;110(5):764-76. doi: 10.1161/CIRCRESAHA.111.253104. Review.

Supplemental Content

Support Center